Arca
Skip to content

Warning Letter to MyRXCash

Unspecified. See MyRXCash's company page.

On Sep 19, 2017, FDA's CDER sent MyRXCash a warning letter citing unapproved new drug, labeling.

  • Letter date: Sep 19, 2017
  • Issued by: CDER
  • Closeout: —

The Letter

As posted on FDA.gov ↗; cited 21 CFR sections link to their page.

FDA's site did not return the letter just now. Read it on FDA.gov ↗

Recent Letters Citing Unapproved new drug

See them all

Record

Recipient
—
FDA site ID (FEI)
—

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.